Study confirms post-pandemic rise in disorders of gut-brain interaction

	Hepatology
	The latest hepatology news from News Medical

	Study confirms post-pandemic rise in disorders of gut-brain interaction A new international study confirmed a significant post-pandemic rise in disorders of gut-brain interaction, including irritable bowel syndrome (IBS) and functional dyspepsia, according to the paper published in Clinical Gastroenterology and Hepatology.

	Heavy drinking now poses greater liver disease risk than two decades ago Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, according to a new Keck Medicine of USC study published today in Clinical Gastroenterology and Hepatology.

			Blocking nutrient scavenging weakens pancreatic tumor defenses Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, tumors develop in and alter the nearby milieu of immune cells, connective tissue, blood vessels and a sea of proteins and carbohydrates that provide structure and other supportive functions.

			Vitamin D supplementation reduces liver inflammation and fibrosis largely through TXNIP Chronic liver disease (CLD) is a major global health concern, affecting approximately 1.5 billion people. This life-threatening disease often progresses silently, eventually leading to worsened conditions like liver cirrhosis or liver cancer.

			Salk researcher awarded funding to boost immunotherapy for pancreatic cancer Salk Institute Professor Diana Hargreaves was named a 2025 All-Star Translational Award Program grantee by the V Foundation for Cancer Research.

	AI tool helps doctors predict hospital death risk in cirrhosis patients Predicting who might die while in the hospital is one of the hardest challenges for doctors caring for people with serious liver disease.

	WHO urges urgent action to eliminate hepatitis and reduce liver cancer deaths As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths.

	Rising liver cancer rates highlight need for urgent action worldwide The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called non-alcoholic fatty liver disease), suggests an analysis as part of The Lancet Commission on liver cancer.

	Cancer immunotherapies linked to increased risk of liver cholestasis A global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger cholestasis, a serious liver condition where bile flow stalls.

	Promising new treatment helps the immune system attack and destroy liver tumors Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025